Enablers of the implementation of tissue plasminogen activator in acute stroke care: a cross-sectional survey

PLoS One. 2014 Dec 9;9(12):e114778. doi: 10.1371/journal.pone.0114778. eCollection 2014.

Abstract

Objective: To assess emergency physicians' perceptions of individual and system enablers to the use of tissue Plasminogen Activator in acute stroke.

Method: Australian fellows and trainees of Australasian College for Emergency Medicine completed a 57-item online survey assessing enablers to implementation of evidence-based practice across six domains: knowledge, skills, modelling, monitoring, feedback, and maintenance. Demographic and workplace characteristics were obtained. Descriptive statistics were calculated to describe demographic and workplace characteristics of responders, and survey responses. Each domain received an overall score (%) based on the number of responders agreeing with all items within the domain.

Results: A total of 429 (13%) Australasian College for Emergency Medicine members responded. 17.7% of respondents reported they and/or their workplace met all knowledge-related enablers, however only 2.3% had all skill-related enablers in place. Of respondents who decide which patients receive tissue Plasminogen Activator treatment, 18.1% agreed that all maintenance-related enablers are in place at their hospital, compared to 6.6% for those who do not decide which patients receive tissue Plasminogen Activator treatment. None of the respondents had all items in place cross all domains.

Conclusions: Even when allowing for the low response rate, it seems likely there is a lack of individual and system enablers supporting the implementation of best-practice stroke care in a number of Australian hospitals. Quality improvement programs could target all domains, particularly the skills-training and feedback emergency physicians receive, to aid implementation of tissue Plasminogen Activator treatment for acute stroke.

MeSH terms

  • Acute Disease
  • Adult
  • Attitude of Health Personnel*
  • Cross-Sectional Studies
  • Emergency Medicine
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Health Care Surveys
  • Health Knowledge, Attitudes, Practice*
  • Hospitals
  • Humans
  • Male
  • Physicians
  • Quality Improvement*
  • Stroke / drug therapy*
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator

Grants and funding

The authors have no support or funding to report.